Distinguished in Cramp-Fasciculation Syndrome

Ulrike Schmidt-Schara

Essen, NW, DE 
Distinguished in Cramp-Fasciculation Syndrome
Essen, NW, DE 
OverviewLocationsClinical Research

Overview

Ulrike Schmidt-Schara practices in Essen, Germany. Ms. Schmidt-Schara is rated as a Distinguished expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. Her top areas of expertise are Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Cramp-Fasciculation Syndrome, and Duchenne Muscular Dystrophy.

Her clinical research consists of co-authoring 95 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles and participated in 1 clinical trial in the study of Cramp-Fasciculation Syndrome.

Gender
Female

Locations

Essen, NW, Germany
Other Locations
Duisburg, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3

94 Total Publications

Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance.
Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance.
Journal: Journal of neuromuscular diseases
Published: January 16, 2026

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Schmidt-Schara's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile